are commonly rearranged with a limited number of partner loci, the more common trend among the remaining genes was a promiscuous repertoire of rearrangements. The overall diversity and recurrence of SVs affecting CD58 were notably more common than has been previously reported.
Many of the additional examples are known aSHM targets including the PAX5 locus, CD83, and DMD which are subject to double-strand DNA breaks due to AID activity. compared to cases lacking a mutation in the region (red) and they largely represent known or suspected targets of aSHM. ZCCHC7 is adjacent to the PAX5 locus, which contains an enhancer found previously to be recurrently mutated in CLL. These mutations were associated in that study with higher expression of PAX5 14 . (B) Two examples of genes affected by aSHM with higher expression in mutated cases are shown. PRDM1 is a tumour suppressor gene that is commonly mutated and deleted in DLBCL, though here was found to have elevated expression in cases with mutations (mainly intronic). The recurrence of mutations in the first intron identified here, most likely due to aSHM, has not been reported. These mutations were strongly enriched in ABC cases.
Given these mutations were associated with higher expression, the bulk of these is unlikely to be functional, though it is conceivable that a subset of aSHM-derived mutations lead to reduced expression. AICDA, which encodes the AID enzyme, also had a mutation peak enriched in ABC.
The expression of this gene is strongly associated with this molecular subgroup, though these mutations have not been detected by prior studies. we determined the most common annotation per patient/peak combination. In most known aSHM targets, this is typically either 5 flank, 5 UTR or intronic mutations. We identified the genes that had other annotations more common than these as genes less likely to be affected by aSHM. Some of these are RNA genes and thus do not have UTRs (e.g. MALAT1, NEAT1) and many histone genes, which are small and may have a different pattern due to their length but may nonetheless be affected by aSHM. Others are genes with mutation hot spots such as MEF2B, CD79B and EZH2.
Among these genes, NFKBIZ appeared distinct 3 UTR mutations was the only mutation type within its Doppler peak. (B) We identified somatic mutations which lead to significant changes in RNA abundance by comparing the frequency of somatic mutations identified through DNA sequencing with the corresponding frequency obtained from RNA sequencing. For each gene, the proportion of patients in allelic imbalance (AI) was determined by comparing the number of cases with at least one mutation in AI in that gene, to the total number mutated cases. Genes with less than 50% of cases in AI are not shown. within the GCB cases analysed by RNA-seq. We stratified patients into FCGR2B-high and -low strata and tested these two groups for significant differences across a range of thresholds. The P value (left) and hazard ratio (right) showed that any cutoff above the median allowed significant separation of patients on TTP. A similar trend was seen for DSS (not shown). 
